SARS-CoV-2 Envelope Protein Polyklonaler Antikörper
SARS-CoV-2 Envelope Protein Polyklonal Antikörper für ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Virus und mehr (1)
Anwendung
WB, IF, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 28904-1-AP
Synonyme
Geprüfte Anwendungen
Erfolgreiche Detektion in ELISA | Recombinant protein |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Enzyme-linked Immunosorbent Assay (ELISA) | ELISA : |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
WB | See 1 publications below |
IF | See 3 publications below |
Produktinformation
28904-1-AP bindet in WB, IF, ELISA SARS-CoV-2 Envelope Protein und zeigt Reaktivität mit Virus
Getestete Reaktivität | Virus |
In Publikationen genannte Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | SARS-CoV-2 Envelope Protein fusion protein Ag30690 |
Vollständiger Name | COVID-19 E Protein |
GenBank-Zugangsnummer | NC_045512 |
Gene symbol | SARS-CoV-2 Envelope Protein |
Gene ID (NCBI) | 43740570 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol |
Lagerungsbedingungen | Store at -20°C. Stable for one year after shipment. Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).
Publikationen
Species | Application | Title |
---|---|---|
iScience TLR2/NF-κB signaling in macrophage/microglia mediated COVID-pain induced by SARS-CoV-2 envelope protein | ||
Front Cell Neurosci The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model |